Obsessive-compulsive disorder: A neuronal membrane phospholipid hypothesis and concomitant therapeutic strategy

Medical Hypotheses

Volumn 56, Issue 4, 2001, Pages 413-415

  Oken, R J ^a  

^a Hopatcong   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESSENTIAL FATTY ACID; IBUPROFEN; MEMBRANE PHOSPHOLIPID; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; PROSTAGLANDIN SYNTHASE;

ARACHIDONIC ACID METABOLISM; ARTHRITIS; ARTICLE; DATA BASE; DIET SUPPLEMENTATION; DRUG EFFICACY; MANIC DEPRESSIVE PSYCHOSIS; NERVE CELL MEMBRANE; OBSESSION; PARESTHESIA; PREVALENCE; PRIORITY JOURNAL; RHEUMATIC DISEASE; SCHIZOPHRENIA;

EID: 0035035796     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.2000.1147     Document Type: Article

References (26)

1. Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder
2. Local cerebral glucose metabolic rates in obsessive-compulsive disorder
3. Frontal abnormalities in a patient with obsessive-compulsive disorder
4. Regional cerebral blood flow in obsessive-compulsive disordered patients at rest
5. Obsessive-compulsive disorder: Cerebral calcium deficiency as a possible etiologic/pathogenetic factor - A case study
6. Pediatric autoimmune neuropsychiatric disorders associated with streptoccal infections: Clinical description of the first 50 cases
7. The psychopharmacology of obsessive-compulsive disorder: Implications for treatment and pathogenesis
8. Cerebral fluid biogenic amines in obsessive-compulsive disorder, Tourette's syndrome, and healthy controls
9. Clozapine reduces violence and persistent aggression in schizophrenia
10. The membrane hypothesis of schizophrenia
11. Sustained remission of positive and negative symptoms of schizophrenia following treatment with eicosapentaenoic acid
12. Omega-3 fatty acid supplementation in schizophrenic patients
13. Essential fatty acid deficiency in erythrocyte membrane from chronic schizophrenia patients, and the clinical effect of dietary supplementation
14. Aspirin
15. Autisaccade and smooth pursuit performance in patients with schizophrenia and obsessive compulsive disorder
16. Phospholipases as candidate genes in schizophrenia
17. At issue: Schizophrenia and rheumatoid arthritis: The negative association revisited
18. Schizophrenia and rheumatoid arthritis: A review
19. Inhibitory effect of aspirin on cholera toxin-induced phospholipase and cyclooxygenase activity
20. Altered cortical excitability in obsessive-compulsive-disorder
21. A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: More support for a continuum hypothesis of "functional" psychosis
22. Dopamine function in obsessive-compulsive disorder: Growth hormone response to apomorphine stimulation
23. Double blind pilot study of eicosapentaenoic acid as the sole treatment for schizophrenia
24. Lithium decreases turnover of arachidonate in several brain phospholipids
25. Omega 3 fatty acids in bipolar disorder